TABLE 2.
Predictive Markers | Cancer | No Cancer | N | Mean | SEM2 | Median | P value | ||
---|---|---|---|---|---|---|---|---|---|
N | % | N | % | ||||||
Cytology | 59 | 149 | 208 | ||||||
Inadequate | 34 | 58 | 103 | 69 | |||||
Benign | 20 | 34 | 36 | 24 | |||||
Atypical | 3 | 5 | 10 | 7 | |||||
Malignant | 2 | 3 | 0 | 0 | 0.056 | ||||
Palpable | 59 | 149 | 208 | ||||||
Yes | 34 | 34 | 67 | 66 | 101 | ||||
No | 25 | 23 | 82 | 77 | 107 | 0.135 | |||
PSA(ng/g)2 | 121 | ||||||||
Cancer | 37 | 1477.4 | 898.6 | 19.0 | |||||
No Cancer | 84 | 1464.6 | 655.2 | 57.6 | 0.180 | ||||
hK2(ng/g)2 | 106 | ||||||||
Cancer | 36 | 37.4 | 22.5 | 0.0 | |||||
No Cancer | 70 | 42.1 | 17.2 | 0.0 | 0.463 | ||||
bFGF (ng/g)2 | 101 | ||||||||
Cancer | 34 | 41.6 | 17.4 | 3.5 | |||||
No Cancer | 67 | 4.8 | 2.3 | 0.0 | 0.005 | ||||
SPF2 | 66 | ||||||||
Cancer | 18 | 16.2 | 5.6 | 5.8 | |||||
No Cancer | 48 | 7.9 | 1.7 | 4.3 | 0.031 | ||||
DNA Index | 65 | ||||||||
Cancer | 18 | 1.2 | 0.1 | 1.08 | |||||
No Cancer | 47 | 1.1 | 0.0 | 1.05 | 0.383 |
: not all biomarkers were analyzed in all subjects
: bFGF: basic fibroblast growth factor; ng/g: hK2: human glandular kallikrein 2; nanogram of biomarker/gram total protein; PSA: prostate specific antigen; SEM: standard error of the mean; SPF: S phase fraction